Takeda Pharmaceutical Co Ltd (4502.T)
4502.T on Tokyo Stock Exchange
5,095JPY
19 Apr 2018
5,095JPY
19 Apr 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
¥5,095
¥5,095
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
2,406,749
2,406,749
52-wk High
¥6,693
¥6,693
52-wk Low
¥4,898
¥4,898
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -71.44 | March | 19 Apr 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 2 | 2 | 2 | 2 |
| (2) OUTPERFORM | 2 | 2 | 2 | 2 |
| (3) HOLD | 5 | 8 | 8 | 8 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.33 | 2.50 | 2.50 | 2.50 |
Consensus Estimates Analysis
Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-18 | 2 | 410,578.00 | 411,156.00 | 410,000.00 | -- |
| Year Ending Mar-18 | 11 | 1,771,210.00 | 1,809,940.00 | 1,723,500.00 | 1,759,970.00 |
| Year Ending Mar-19 | 11 | 1,783,580.00 | 1,818,500.00 | 1,685,000.00 | 1,797,040.00 |
| Earnings (per share) | |||||
| Quarter Ending Mar-18 | 2 | -71.44 | -60.20 | -82.68 | -- |
| Year Ending Mar-18 | 11 | 216.49 | 248.40 | 200.50 | 150.35 |
| Year Ending Mar-19 | 11 | 192.83 | 273.98 | 141.40 | 151.37 |
| LT Growth Rate (%) | 2 | 8.59 | 12.20 | 4.98 | 14.34 |
Historical Surprises
Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Dec-17 | 447,897.00 | 488,152.00 | 40,255.34 | 8.99 |
| Quarter Ending Sep-17 | 438,894.00 | 433,176.00 | 5,718.00 | 1.30 |
| Quarter Ending Jun-17 | 419,498.00 | 448,240.00 | 28,742.50 | 6.85 |
| Quarter Ending Mar-17 | 400,854.00 | 416,205.00 | 15,350.66 | 3.83 |
| Quarter Ending Dec-16 | 449,358.00 | 465,045.00 | 15,686.66 | 3.49 |
Consensus Estimates Trend
Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-18 | 410,578.00 | 410,426.00 | 413,362.00 | 413,362.00 | -- |
| Year Ending Mar-18 | 1,771,210.00 | 1,770,340.00 | 1,760,630.00 | 1,758,240.00 | 1,759,970.00 |
| Year Ending Mar-19 | 1,783,580.00 | 1,786,600.00 | 1,774,590.00 | 1,774,440.00 | 1,797,040.00 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Mar-18 | 1 | 0 | 1 | 0 |
| Year Ending Mar-18 | 1 | 0 | 3 | 1 |
| Year Ending Mar-19 | 0 | 1 | 3 | 1 |
| Earnings | ||||
Earnings vs. 
Estimates- Deals of the day-Mergers and acquisitions
- Shire rejects $63 billion Takeda bid as Allergan drops pursuit
- UPDATE 5-Shire rejects $63 bln Takeda bid as Allergan drops pursuit
- UPDATE 1-Shire, commodity stocks lift FTSE to 10-week high
- Exclusive: Allergan in talks to acquire Shire, competing against Takeda - sources